A detailed history of Chilton Investment CO Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Chilton Investment CO Inc. holds 10,040 shares of NVO stock, worth $1.17 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
10,040
Previous 4,659 115.5%
Holding current value
$1.17 Million
Previous $598,000 139.63%
% of portfolio
0.04%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$122.71 - $146.91 $660,302 - $790,522
5,381 Added 115.5%
10,040 $1.43 Million
Q1 2024

May 15, 2024

SELL
$102.11 - $135.92 $10,619 - $14,135
-104 Reduced 2.18%
4,659 $598,000
Q4 2023

Feb 14, 2024

SELL
$87.78 - $105.45 $2.72 Million - $3.27 Million
-30,977 Reduced 86.67%
4,763 $492,000
Q3 2023

Nov 14, 2023

BUY
$90.94 - $199.54 $3.25 Million - $7.13 Million
35,740 New
35,740 $3.25 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $263B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Chilton Investment CO Inc. Portfolio

Follow Chilton Investment CO Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chilton Investment CO Inc., based on Form 13F filings with the SEC.

News

Stay updated on Chilton Investment CO Inc. with notifications on news.